The liver kinase B1 is a central regulator of T cell development, activation, and metabolism.
The liver kinase B1 is a central regulator of T cell development, activation, and metabolism.
复制标题
DOI:
10.4049/jimmunol.1100367
复制
发表时间:
2011-10-15
期刊:
影响因子:
--
通讯作者:
Jones RG
中科院分区:
文献类型:
--
作者:
MacIver NJ;Blagih J;Saucillo DC;Tonelli L;Griss T;Rathmell JC;Jones RG
T cell activation leads to engagement of cellular metabolic pathways necessary to support cell proliferation and function. However, our understanding of the signal transduction pathways that regulate metabolism and their impact on T cell function remains limited. The Liver Kinase B1 (LKB1) is a serine/threonine kinase that links cellular metabolism with cell growth and proliferation. Here we demonstrate that LKB1 is a critical regulator of T cell development, viability, activation, and metabolism. T cell-specific ablation of the gene that encodes LKB1 resulted in blocked thymocyte development and a reduction in peripheral T cells. LKB1-deficient T cells exhibited defects in cell proliferation and viability, and altered glycolytic and lipid metabolism. Interestingly, loss of LKB1 promoted increased T cell activation and inflammatory cytokine production by both CD4+ and CD8+ T cells. Activation of the AMP-activated protein kinase (AMPK) was decreased in LKB1-deficient T cells. AMPK was found to mediate a subset of LKB1 functions in T lymphocytes, as mice lacking the α1 subunit of AMPK displayed similar defects in T cell activation, metabolism, and inflammatory cytokine production, but normal T cell development and peripheral T cell homeostasis. LKB1- and AMPKα1-deficient T cells each displayed elevated mTORC1 signaling and IFN-γ production that could be reversed by rapamycin treatment. Our data highlight a central role for LKB1 in T cell activation, viability, and metabolism, and suggest that LKB1-AMPK signaling negatively regulates T cell effector function through regulation of mTOR activity.
登录
查看更多内容
影响因子:
--
作者:
Hawley SA;Boudeau J;Reid JL;Mustard KJ;Udd L;Mäkelä TP;Alessi DR;Hardie DG
通讯作者:
Hardie DG
DOI:
10.4049/jimmunol.0902593
发表时间:
2010-04-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Jacobs SR;Michalek RD;Rathmell JC
通讯作者:
Rathmell JC
DOI:
10.1038/nri2888
发表时间:
2011-02
期刊:
Nature reviews. Immunology
影响因子:
--
作者:
通讯作者:
--
影响因子:
32.4
作者:
Jones, Russell G.;Bui, Thi;Thompson, Craig B.
通讯作者:
Thompson, Craig B.
影响因子:
3.3
作者:
BENTAL, M;DEUTSCH, C
通讯作者:
DEUTSCH, C